Back to search

Netherlands· NL-ce4f11d4551a

Yondelis 1 mg, poeder voor concentraat voor oplossing voor infusie

A trabectedin product containing trabectedine, registered in Netherlands by Pharma Mar S.A.. The same ATC class is registered in 17 of our 19 countries.

ATC L01CX01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedYondelis 1 mg, poeder voor concentraa…ATCL01CX01REGISTER NO.NL-ce4f11d4551aPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Trabectedin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01CX01 (trabectedin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Trabectedin · ATC L01CX01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trabectedin costs, country by country.

Normalised to the WHO defined daily dose (0.13 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trabectedin · price per daily dose (0.13 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$226.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TRABECTEDINE
Manufacturer
Pharma Mar S.A.
Country
Netherlands (NL)
ATC code
L01CX01
ATC class
Trabectedin
Defined daily dose
0.13 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/07/417

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

502 interactions on record for trabectedin.

Graded by severity as the source publishes them — 72 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trabectedin · interactions on record

502 records

  • 72 severe
  • 430 moderate

Most severe, free to view

  • LonafarnibA16AX20severe
  • ConivaptanC03XA02severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trabectedin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trabectedin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Trabectedin Ever Pharma, Trabectedin Stada
  • Belgium · Trabectedin Eg (Eurogenerics), Trabectedin Ever Pharma
  • Bulgaria · Трабектедин Ever Pharma
  • Czechia · Trabectedin Ever Pharma
  • Germany · Trabectedin Ever Pharma, Trabectedin Ratiopharm
  • Denmark · Trabectedin Teva, Trabektedin
  • Estonia · Trabectedin Ever Pharma
  • Spain · Trabectedina, Trabectedina Ever Pharma
  • Finland · Trabectedin, Trabectedin Ever Pharma
  • France · Trabectedin, Trabectedin Ever Pharma
  • United Kingdom (Northern Ireland) · Trabectedin Accord Healthcare, Trabectedin Genus Pharmaceuticals Ltd.
  • Greece · Trabectedin Ever Pharma, Trabectedin Teva
  • Croatia · Trabektedin Ever Pharma, Trabektedin Teva
  • Hungary · Trabectedin, Trabectedin Ever Pharma
  • Ireland · Trabectedin Ever Pharma
  • Iceland · Trabectedin Accord, Yondelis
  • Italy · Trabectedina Eg Spa, Trabectedina Ever Pharma
  • Liechtenstein · Trabectedin Accord, Yondelis
  • Lithuania · Trabectedin Ever Pharma
  • Luxembourg · Trabectedin Eg (Eurogenerics) Nv, Trabectedine Teva
  • Latvia · Trabectedin Ever Pharma
  • Norway · Trabectedin, Trabectedin Accord
  • Poland · Trabectedin Ever Pharma
  • Portugal · Trabectedina Ever Pharma, Trabectedina Teva
  • Romania · Trabectedin Ever Pharma, Trabectedin Teva
  • Sweden · Trabectedin Ever Pharma, Trabectedin Stada
  • Slovenia · Trabektedin Ever Pharma, Trabektedin Teva
  • Slovakia · Trabectedin Ever Pharma, Trabectedin Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6423ebf-63f4-4e33-a537-34cdd614f5d9
GET /v1/drugs/b6423ebf-63f4-4e33-a537-34cdd614f5d9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/yondelis-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Trabectedin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp73412",
  "excipients": [
    "FOSFORZUUR (E 338)",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "KALIUMHYDROXIDE (E 525)",
    "SACCHAROSE"
  ],
  "substances": [
    "TRABECTEDINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2007/09/17",
  "procedure_number": "EMEA/H/C/000773",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/07/417",
  "additional_monitoring": "N"
}

See everything about trabectedin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.